Glutathione is a tripeptide, three amino acids (glutamate, cysteine, and glycine) linked into a single small molecule, that every cell synthesizes and relies on as its central chemical defense. The published biochemistry describes it as the body's master antioxidant: it neutralizes reactive oxygen species before they damage DNA, proteins, and membranes, regenerates spent vitamins C and E, and drives the liver's phase two detoxification. Concentrations are highest in the liver and decline with age, chronic disease, and oxidative stress, which is why glutathione status is tied so closely to cellular health.
Glutathione is a cysteine-containing tripeptide present in nearly every cell at roughly 1 to 10 millimolar, functioning as the body's principal intracellular antioxidant and the driver of hepatic phase two detoxification.
Glutathione is built from L-glutamate, L-cysteine, and glycine, but its defining feature is not the amino acids themselves. An unusual gamma peptide bond links the side-chain carboxyl of glutamate to cysteine instead of the standard alpha bond, and that linkage makes the molecule resistant to ordinary intracellular peptidases, so it accumulates to millimolar levels without rapid breakdown. The reactive thiol on the cysteine residue does the chemical work, which is why cysteine availability is the rate-limiting factor in how much glutathione a cell can build.
Glutathione's gamma-glutamyl bond, not the standard alpha peptide bond, is what shields the C10H17N3O6S tripeptide from intracellular peptidases and lets it reach millimolar concentrations inside cells.
Glutathione scavenges oxidants by donating an electron from its cysteine thiol, converting hydrogen peroxide, hydroxyl radicals, and lipid peroxides into water or stable alcohols. Much of this runs through glutathione peroxidase, a selenium-dependent enzyme that spends two glutathione molecules to reduce one molecule of hydrogen peroxide. What separates it from dietary antioxidants is that it is manufactured on demand inside every cell and recharges the rest of the antioxidant network rather than being consumed once.
Glutathione peroxidase consumes two reduced glutathione molecules to convert one molecule of hydrogen peroxide into water, making the reduced-to-oxidized ratio one of the most reliable biochemical readouts of oxidative stress.
Cells build glutathione fresh in a two-step, energy-dependent reaction in the cytoplasm, and just as importantly, they recycle it rather than consuming it permanently. Cysteine is normally the limiting ingredient, which is why cysteine precursors are the usual lever for raising glutathione. The recycling side ties glutathione status to broader metabolic health, because regeneration depends on NADPH supplied largely by the pentose phosphate pathway.
Glutamate-cysteine ligase catalyzes the rate-limiting first step of glutathione synthesis, and cysteine, the least abundant of the three amino acids, is typically the ingredient that limits how much a cell can produce.
Reduced and oxidized glutathione are the same molecule captured at two ends of one working cycle. Reduced glutathione (GSH) carries a free thiol ready to donate an electron, while oxidized glutathione (GSSG) is two molecules joined by a disulfide bridge after each has given up an electron. Healthy cells hold roughly nine or more parts reduced to every one part oxidized, and that ratio falls under oxidative stress, which is why it serves as a sensitive marker of a cell's redox status.
| Property | Reduced (GSH) | Oxidized (GSSG) |
|---|---|---|
| Structure | Single molecule, free thiol | Two molecules, disulfide bond |
| Redox role | Donates electrons | Spent after donation |
| Cellular share | ~90% or more | ~10% or less |
| Restored by | Already active | Glutathione reductase and NADPH |
Healthy cells maintain a reduced-to-oxidized glutathione ratio of roughly 9 to 1 or higher, and a drop in that ratio is used in research and some clinical settings as a sensitive indicator of oxidative burden.
Glutathione is present in essentially every cell, but its concentration tracks how much oxidative and detoxification work a tissue performs. The liver holds the largest stores and exports glutathione and its precursors to supply other organs, while tissues under constant oxidative challenge, such as the lungs and the lens of the eye, carry rich reserves of their own.
The liver holds the body's largest glutathione stores, and because mitochondria cannot make their own and must import it, depletion of the smaller mitochondrial pool is closely tied to cell injury and death.
In the liver, glutathione is the central agent of phase two detoxification, the conjugation stage that makes reactive intermediates safe for excretion. After phase one enzymes activate a drug or toxin into a more reactive intermediate, glutathione binds it through the thiol group, a reaction accelerated by glutathione S-transferases, producing a water-soluble conjugate that can be eliminated. Acetaminophen is the clinically vital example: its toxic metabolite is disarmed almost entirely by glutathione conjugation, and the overdose antidote works by replenishing cysteine to rebuild glutathione stores.
Glutathione conjugation, accelerated by glutathione S-transferases, is the phase two reaction that neutralizes acetaminophen's toxic metabolite, and an overdose that exhausts hepatic glutathione is treated by replenishing cysteine to rebuild stores.
Glutathione availability effectively sets a ceiling on the vigor of an immune response, because T lymphocytes cannot mount a strong clonal expansion when their internal redox environment is depleted. It also shapes the character of that response, helping balance the Th1 pathway that drives cell-mediated antiviral defense against the Th2 antibody pathway, so depletion can skew defenses away from effective antiviral immunity.
Adequate glutathione is required for T-lymphocyte proliferation, and low glutathione status is repeatedly associated with impaired immunity, greater susceptibility to infection, and blunted responses in the elderly and chronically ill.
Glutathione is not fixed. Across later decades of life the activity of its synthesizing enzymes falls while oxidative burden climbs, so production slips just as demand grows and measurable tissue levels drop. Chronic diseases such as diabetes, liver disease, and neurodegenerative disorders compound the drain through sustained oxidative stress, and nutritional shortfalls of cysteine, selenium, and riboflavin throttle both synthesis and recycling.
Tissue glutathione declines measurably with age as synthesizing-enzyme activity falls and oxidative burden rises, and chronic disease, cysteine and selenium shortfalls, alcohol, and smoking each accelerate the loss.
Educational use only. This article describes what the published scientific and clinical literature reports about Glutathione. It is not medical advice, and it does not recommend, prescribe, or tell anyone to use anything described here. The regulatory status shown at the top of this page reflects what the record showed on the date given there and can change. mdpep.com does not sell any substance described here, does not endorse human use of it, and does not direct anyone to obtain it.
This is not guidance for your situation. Nothing here accounts for your medical history, your current medications, or anything else specific to you, and none of it should be used to make a decision about your own health.
Affiliate disclosure. Some links on this site are affiliate links, and mdpep.com may earn a commission when they are used. That never affects what is written here, it is not an endorsement of any vendor, and it is not a statement that anything described on this page is available to buy.
Every claim here ties to a named primary source and a date, written as plain documentation with nothing for sale. That is how MD PEP covers the whole peptide market.
